Recently, we found that compound A, a plant derivative known to function as a GR agonist as well as an AR antagonist, induced only GR transrepression in bladder cancer cells and more efficiently inhibited tumor growth than dexamethasone or an antiandrogen flutamide [61]. Here, AR is linked to urinary bladder carcinoma.